Medical Meeting Regulations - compliance burden or opportunity for growth?

Medical Meeting Regulations - compliance burden or opportunity for growth?

30-11-2017, 13:15 - 14:00

Knowledge Theatre 2


Ever more widespread regulations create a challenge but also offer a catalyst for positive change. Direct sponsorship of doctors is allowed by the pharmaceutical sector, whereas it is being banned by MedTech. Meeting meetings need to be vetted for eligibility before receiving industry support. As the medical meetings industry becomes more regulated, educational providers are faced with adapting their work processes and even their business models. The whole sector is in the midst of a transformation, with a broad range of stakeholders (including attendees, sponsors, organisers and venues) being directly affected. 

(Earn 0.75 CE Credit at the completion of this session as part of the CMP Preferred Provider Program)


  • Simon Dufaur


    Head of Strategy

    Innovation & Consulting, MCI Group

    Simon Dufaur is the Head of Strategy, Innovation and Consulting at MCI and works with leading international medical association and corporations to...

We use cookies to operate this website and to improve its usability. Full details of what cookies are, why we use them and how you can manage them can be found by reading our Privacy & Cookies page. Please note that by using this site you are consenting to the use of cookies.